Docking Protein 3 Activators are a diverse group of chemicals that can influence the function or expression of Docking Protein 3 through various signaling pathways. For instance, Forskolin is notable for its ability to activate adenylate cyclase, which in turn elevates the levels of cAMP, a secondary messenger that can stimulate Docking Protein 3. Similarly, Phorbol 12-myristate 13-acetate (PMA) activates Protein Kinase C (PKC), which may modify or interact with Docking Protein 3. EGF and IGF-1, which activate the EGFR and PI3K/AKT pathways respectively, can engage with Docking Protein 3 as part of their downstream effects. Curcumin and Resveratrol are known to modulate various cellular pathways, including NF-kB and Sirt1, respectively, which in turn can impact Docking Protein 3. Sodium Butyrate, a histone deacetylase inhibitor, can upregulate the gene expression of Docking Protein 3.
The activators also include chemicals like Anandamide, which interacts with endocannabinoid receptors, Bradykinin, which activates the B2 receptor, and Lysophosphatidic Acid, which stimulates G-protein coupled receptors. Each of these interactions has the capability to influence Docking Protein 3 by modulating related cellular processes. Caffeine, a stimulant, can influence the protein through its ability to raise intracellular cAMP levels. Lastly, Melatonin holds significance as it can modulate various signaling pathways to engage with Docking Protein 3. Overall, these chemicals share the common characteristic of being able to modulate either the activity, interaction, or expression of Docking Protein 3 through distinct mechanisms and signaling pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, increasing cAMP levels that can stimulate the protein | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC which may interact with or modify Docking protein 3 | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Affects various cellular pathways, including NF-kB, potentially influencing the protein | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Affects Sirt1 and other cellular pathways that may engage Docking protein 3 | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Raises intracellular cAMP levels, potentially affecting Docking protein 3 | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Histone deacetylase inhibitor, may upregulate gene expression of Docking protein 3 | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
Activates G-protein coupled receptors, potentially affecting Docking protein 3 | ||||||
Melatonin | 73-31-4 | sc-207848 sc-207848A sc-207848B sc-207848C sc-207848D sc-207848E | 1 g 5 g 25 g 100 g 250 g 1 kg | $65.00 $73.00 $218.00 $697.00 $1196.00 $3574.00 | 16 | |
Modulates various signaling pathways that may engage Docking protein 3 | ||||||